Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Cancer Res (2020) 80 (10): 2031–2044.

https://doi.org/10.1158/0008-5472.CAN-19-1077

Published: 15 May 2020

View article titled, Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Includes: Supplementary data

Journal Articles

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

Cancer Res (2018) 78 (14): 4059–4072.

https://doi.org/10.1158/0008-5472.CAN-18-0327

Published: 15 July 2018

View article titled, LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

Includes: Supplementary data

Journal Articles

Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085

Eytan Ben-Ami, Ying Huang, Prafulla C. Gokhale, Benjamin Eschle, Lisa Durkin, Jonathan Hickson, Mien Sho, Susan Morgan-Lappe, Kurt Gish, Dominic W. Lai, Randy R. Robinson, Diane Hollenbaugh, Eric D. Hsi, Debra T. Chao, George D. Demetri, James W. Purcell

Cancer Res (2018) 78 (13_Supplement): 953.

https://doi.org/10.1158/1538-7445.AM2018-953

Published: 01 July 2018

View article titled, Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085

Journal Articles

MYD88 L265P Mutation in Lymphoid Malignancies

Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric D. Hsi, Ken H. Young, Mingzhi Zhang, Yong Li

Cancer Res (2018) 78 (10): 2457–2462.

https://doi.org/10.1158/0008-5472.CAN-18-0215

Published: 14 May 2018

View article titled, <em>MYD88</em> L265P Mutation in Lymphoid Malignancies

Includes: Supplementary data

Journal Articles

Abstract 2444: Recurrent mutations and clinical outcomes in patients with follicular lymphoma

Kilannin Krysiak, Cody Ramirez, Felicia Gomez, Christopher A. Miller, Robert S. Fulton, Friederike Kreisel, Amanda F. Cashen, Nancy L. Bartlett, Ana Ruano, Eric D. Hsi, Malachi Griffith, Obi L. Griffith, Todd A. Fehniger

Cancer Res (2017) 77 (13_Supplement): 2444.

https://doi.org/10.1158/1538-7445.AM2017-2444

Published: 01 July 2017

View article titled, Abstract 2444: Recurrent mutations and clinical outcomes in patients with follicular lymphoma

Journal Articles

Abstract 3337: Targeting acute myeloid leukemia via anti-IL1RAP antibodies

Ping Jiang, Bob Y. Liu, Jen Huang, Jennifer Lu, Sharmili Roy, Madhavi Mishra, Xiaoxian Zhao, Jeffrey Lin, Eric D. Hsi, Jagath R. Junutula

Cancer Res (2016) 76 (14_Supplement): 3337.

https://doi.org/10.1158/1538-7445.AM2016-3337

Published: 15 July 2016

View article titled, Abstract 3337: Targeting acute myeloid leukemia via anti-IL1RAP antibodies

Journal Articles

Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy

Eric D. Hsi, Kerry J. Savage, Sonali M. Smith, Fritz Offner, Scott P. Myrand, Thomas M. Habermann, Donald E. Thornton, Boris K. Lin, Tuan S. Nguyen, Oday Hamid, Michael Crump

Cancer Res (2015) 75 (15_Supplement): 5303.

https://doi.org/10.1158/1538-7445.AM2015-5303

Published: 01 August 2015

View article titled, Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy

Journal Articles

Abstract 662: Generation and characterization of antibodies specific for IL1RAP antigen to target quiescent and proliferating AML leukemic stem cells

Ping Jiang, Sharmili Roy, Jen Huang, Trang Dao-Pick, Jennifer Lu, Madhavi Mishra, Jeffrey Lin, Eric D. Hsi, Robert J. Tressler, Holger Karsunky

Cancer Res (2014) 74 (19_Supplement): 662.

https://doi.org/10.1158/1538-7445.AM2014-662

Published: 01 October 2014

View article titled, Abstract 662: Generation and characterization of antibodies specific for IL1RAP antigen to target quiescent and proliferating AML leukemic stem cells

Journal Articles

Abstract 1033: Distinct response of chronic lymphocytic leukemia cells to PI-3Kδ inhibitor GS-1101 is related to MAPK signaling and likely associated with IGHV mutation.

Xiaoxian Zhao, Juraj Bodo, Eric D. Hsi

Cancer Res (2013) 73 (8_Supplement): 1033.

https://doi.org/10.1158/1538-7445.AM2013-1033

Published: 15 April 2013

View article titled, Abstract 1033: Distinct response of chronic lymphocytic leukemia cells to PI-3Kδ inhibitor GS-1101 is related to MAPK signaling and likely associated with IGHV mutation.

Journal Articles

Abstract 1208: Discovery of a previously undescribed cutaneous T-cell neoplasm with chromosomal rearrangements of 6p25.3.

Andrew L. Feldman, Laszlo J. Karai, Marshall E. Kadin, Eric D. Hsi, Jason C. Sluzevich, Rhett P. Ketterling, Ryan A. Knudson

Cancer Res (2013) 73 (8_Supplement): 1208.

https://doi.org/10.1158/1538-7445.AM2013-1208

Published: 15 April 2013

View article titled, Abstract 1208: Discovery of a previously undescribed cutaneous T-cell neoplasm with chromosomal rearrangements of 6p25.3.

Journal Articles

Abstract 2525: JL1 is a cell surface molecule of acute leukemia blasts: Potential for targeted immunotherapy

Xiaoxian Zhao, Sarah Pogue, Jeffrey Lin, Mingying Bi, David Wilson, Eric D. Hsi

Cancer Res (2012) 72 (8_Supplement): 2525.

https://doi.org/10.1158/1538-7445.AM2012-2525

Published: 15 April 2012

View article titled, Abstract 2525: JL1 is a cell surface molecule of acute leukemia blasts: Potential for targeted immunotherapy

Journal Articles

Abstract 3735: Dasatinib induces dephosphorylation of tyrosine proteins and apoptosis in both B-cell lymphoma lines and primary B-cell Non-Hodgkin Lymphoma cells in vitro for a subgroup of patients with phospho-Src (Y416) expression

Xiaoxian Zhao, Eric D. Hsi

Cancer Res (2010) 70 (8_Supplement): 3735.

https://doi.org/10.1158/1538-7445.AM10-3735

Published: 15 April 2010

View article titled, Abstract 3735: Dasatinib induces dephosphorylation of tyrosine proteins and apoptosis in both B-cell lymphoma lines and primary B-cell Non-Hodgkin Lymphoma cells in vitro for a subgroup of patients with phospho-Src (Y416) expression

Journal Articles

Abstract 5411: Combination of enzastaurin and HDAC inhibitors synergically induces apoptosis in lymphoma cells

Juraj Bodo, Jan Sedlak, Jaroslaw P. Maciejewski, Eric D. Hsi

Cancer Res (2010) 70 (8_Supplement): 5411.

https://doi.org/10.1158/1538-7445.AM10-5411

Published: 15 April 2010

View article titled, Abstract 5411: Combination of enzastaurin and HDAC inhibitors synergically induces apoptosis in lymphoma cells

Journal Articles

Dead or Dying: Necrosis versus Apoptosis in Caspase-deficient Human RenalCell Carcinoma

Vladimir Kolenko, Robert G. Uzzo, Ronald Bukowski, Neil H. Bander, Andrew C. Novick, Eric D. Hsi, James H. Finke

Cancer Res (1999) 59 (12): 2838–2842.

Published: 15 June 1999

View article titled, Dead or Dying: <subtitle>Necrosis <em>versus</em> Apoptosis in Caspase-deficient Human RenalCell Carcinoma</subtitle>

NARROW

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085

MYD88 L265P Mutation in Lymphoid Malignancies

Abstract 2444: Recurrent mutations and clinical outcomes in patients with follicular lymphoma

Abstract 3337: Targeting acute myeloid leukemia via anti-IL1RAP antibodies

Abstract 5303: Correlative results from PRELUDE, a phase III study of enzastaurin (ENZA) vs placebo (PBO) in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL) following a response to R-CHOP therapy

Abstract 662: Generation and characterization of antibodies specific for IL1RAP antigen to target quiescent and proliferating AML leukemic stem cells

Abstract 1033: Distinct response of chronic lymphocytic leukemia cells to PI-3Kδ inhibitor GS-1101 is related to MAPK signaling and likely associated with IGHV mutation.

Abstract 1208: Discovery of a previously undescribed cutaneous T-cell neoplasm with chromosomal rearrangements of 6p25.3.

Abstract 2525: JL1 is a cell surface molecule of acute leukemia blasts: Potential for targeted immunotherapy

Abstract 3735: Dasatinib induces dephosphorylation of tyrosine proteins and apoptosis in both B-cell lymphoma lines and primary B-cell Non-Hodgkin Lymphoma cells in vitro for a subgroup of patients with phospho-Src (Y416) expression

Abstract 5411: Combination of enzastaurin and HDAC inhibitors synergically induces apoptosis in lymphoma cells

Dead or Dying: Necrosis versus Apoptosis in Caspase-deficient Human RenalCell Carcinoma

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only